Janiczek Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $423K | Buy |
903
+202
| +29% | +$94.7K | 0.09% | 94 |
|
|
2024
Q1 | $293K | Buy |
701
+120
| +21% | +$50.2K | 0.06% | 135 |
|
|
2023
Q4 | $236K | Buy |
581
+18
| +3% | +$7.32K | 0.06% | 140 |
|
|
2023
Q3 | $196K | Buy |
563
+257
| +84% | +$89.4K | 0.05% | 145 |
|
|
2023
Q2 | $108K | Buy |
306
+38
| +14% | +$13.4K | 0.03% | 202 |
|
|
2023
Q1 | $89.4K | Buy |
268
+55
| +26% | +$18.3K | 0.03% | 232 |
|
|
2022
Q4 | $63.1K | Buy |
213
+24
| +13% | +$7.11K | 0.02% | 284 |
|
|
2022
Q3 | $56K | Sell |
189
-7
| -4% | -$2.07K | 0.02% | 289 |
|
|
2022
Q2 | $55K | Buy |
196
+14
| +8% | +$3.93K | 0.02% | 291 |
|
|
2022
Q1 | $47K | Buy |
182
+49
| +37% | +$12.7K | 0.01% | 311 |
|
|
2021
Q4 | $29K | Buy |
133
+67
| +102% | +$14.6K | 0.01% | 421 |
|
|
2021
Q3 | $12K | Buy |
66
+19
| +40% | +$3.46K | ﹤0.01% | 552 |
|
|
2021
Q2 | $9K | Sell |
47
-16
| -25% | -$3.06K | ﹤0.01% | 577 |
|
|
2021
Q1 | $14K | Sell |
63
-62
| -50% | -$13.8K | 0.01% | 469 |
|
|
2020
Q4 | $30K | Buy |
125
+116
| +1,289% | +$27.8K | 0.01% | 282 |
|
|
2020
Q3 | $2K | Sell |
9
-5
| -36% | -$1.11K | ﹤0.01% | 528 |
|
|
2020
Q2 | $4K | Buy |
+14
| New | +$4K | ﹤0.01% | 217 |
|